Efficacy of Empagliflozin in Slowing the Progression of Renal Disease in Patients with Type 2 Diabetes: Single-Blind Interventional Study with Placebo Control at Tertiary Care Setting Quetta. L&S. 2025;6(4):06. doi:10.37185/LnS.1.1.870